Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial

Objectives To evaluate whether the effectiveness and safety of low (81 mg daily) versus high-dose (325 mg daily) aspirin is consistent across races among patients with established atherosclerotic cardiovascular disease (ASCVD).Design A secondary analysis of the randomised controlled trial ADAPTABLE...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Saket Girotra, Sunil Kripalani, Adrian F Hernandez, Catherine P Benziger, Hillary Mulder, Peter M Farrehi, Lisa M Wruck, Russell Rothman, Guillaume Marquis-Gravel, Jeff Whittle, Kamal Gupta, Mark B Effron, Daniel Muñoz, Tamar S Polonsky, Robert Harrington, WS Jones
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2024-08-01
Colecção:	BMJ Open
Acesso em linha:	https://bmjopen.bmj.com/content/14/8/e078197.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!